Presentations: Codeine up-scheduling workshop, Wagga Wagga, 14 December 2017

3 January 2018

The TGA held a series of workshops on the up-scheduling of codeine in November-December 2017. Below are the presentations from the Wagga Wagga workshop.

For further information about changes to medicines containing codeine, see the Codeine information hub.

Disclaimer

These presentation papers are provided on the TGA's website solely for the purpose of indicating or suggesting what TGA representatives spoke about to the various conferences and seminars to which it relates. The papers are not legislative in nature and should not be taken to be statements of any law or policy in any way.

The Australian Government Department of Health (of which the TGA is a part) advises that (a) the presentation papers should not be relied upon in any way as representing a comprehensive description of regulatory requirements, and (b) cannot guarantee, and assumes no legal liability or responsibility for, the accuracy, currency or completeness of the information contained in the presentation paper.

How to access a pdf document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open it from there.

Changes to codeine product access

  • Presented by: Adjunct Professor Tim Greenaway, Chief Medical Adviser, Health Products Regulation Group/TGA, Department of Health
  • Presented at: Codeine up-scheduling workshop, Wagga Wagga, 14 December 2017
  • Presentation summary: This presentation provides an overview of the background to the decision to up-schedule codeine-containing compounds.

Presentation: Changes to codeine product access: background to the decision to change from over-the-counter to prescription only (pdf,669kb)*

Additional communication and education activities to support the transition of codeine from over-the-counter to prescription only

  • Presented by: Avi Rebera, Assistant Secretary, Regulatory Education and Planning, Health Product Regulation Group, Department of Health
  • Presented at: Codeine up-scheduling workshop, Wagga Wagga, 14 December 2017
  • Presentation summary: This presentation provides an overview of the communication and education activities being supported by the government as part of the transition for the up-scheduling of codeine.

Presentation: Additional communication and education activities to support the transition of codeine from over-the-counter to prescription only (pdf,322kb)

Management options for chronic non- cancer pain

  • Presented by: Dr Suyin Tan, Clinical Director Anaesthesia & Pain management
  • Presented at: Codeine up-scheduling workshop, Wagga Wagga, 14 December 2017
  • Presentation summary: This presentation provides an overview on new approaches for chronic pain.

Presentation: Management options for chronic non- cancer pain (pdf,621kb)*

Implications for rural and remote communities

  • Presented by: Peta Rutherford, CEO Rural Doctor’s Association of Australia
  • Presented at: Codeine up-scheduling workshop, Wagga Wagga, 14 December 2017
  • Presentation summary: Preparing rural clinicians and the communities they live and work in.

Presentation: Implications for rural and remote communities (pdf,89kb)